Multicenter, Randomised, Double-blind Phase III Trial to Investigate the Efficacy and Safety of BIBF 1120 in Combination With Carboplatin and Paclitaxel Compared to Placebo Plus Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer

The trial will be performed to evaluate if BIBF 1120 in combination with paclitaxel and carboplatin is more effective than placebo in combination with paclitaxel and carboplatin in first-line treatment of patients with advanced ovarian cancer. Safety information about BIBF1120/paclitaxel/carboplatin will be obtained.

本临床试验旨在评估BIBF 1120联合紫杉醇与卡铂的方案，对比安慰剂联合紫杉醇与卡铂方案，在晚期卵巢癌患者一线治疗中的有效性是否更优。同时将收集BIBF 1120/紫杉醇/卡铂联合疗法的安全性相关信息。